Pharmacopuncture, or herbal acupuncture, is a new form of therapy derived from combinations of two traditional therapeutic methods, herbal medicine and acupuncture therapy. To compare the efficacy between dexamethasone-pharmacopuncture (DP) and dexamethasone-oral administration (DO), the effect of DP was investigated in murine models. Anti-anaphylactic effects of dexamethasone treatments were investigated in compound 48/80-induced systemic anaphylactic reaction, ear swelling response, and passive cutaneous anaphylaxis (PCA). DP treatment significantly inhibited the compound 48/80-induced systemic anaphylactic reaction, ear swelling response, and PCA. The effects between DP and DO were on a similar level. These results indicate that DP can be used as an alternative method for DO in case of emergency.
Alfonso A, Cabado AG, Vieytes MR, Botana LM. Functional compartments in rat mast cells for cAMP and calcium on histamine release. Cell Signal. 2000;12:343-350.
Barnes PJ. How corticosteroids control inflammation. Quintiles Prize Lecture 2005. Br J Pharmacol. 2006;148:245-254.
Bazin H, Barta O, Barta VD. Hypersensibility de type I. In Immunologie Animale. Pastoret P, Govaerts A, Bazin H eds. (Paris, France: Flammarion), p. 313, 1990.
Blaser C, Wittwer M, Grandgirard D, Leib SL. Adjunctive dexamethasone affects the expression of genes related to inflammation, neurogenesis and apoptosis in infant rat pneumococcal meningitis. PLoS One. 2011;6:e17840.
Chadi A, Fraundorfer PF, Beaven MA. Compound 48/80 activates mast cell phospholipase D via heterotrimeric GTP-binding proteins. J Pharmacol Exp Ther. 2000;292:122-130.
Daeron M: Fc receptor biology. Annu Rev Immunol 1997;15:203-234.
Emi M, Maeyama K. The biphasic effects of cyclopentenone prostaglandins, prostaglandin J(2) and 15-deoxy-Delta(12,14)-prostaglandin J(2) on proliferation and apoptosis in rat basophilic leukemia (RBL-2H3) cells. Biochem Pharmacol. 2004;67:1259-1267.
Galli SJ, Kalesnikoff J, Grimbaldeston MA, Piliponsky AM, Williams CM, Tsai M. Mast cells as "tunable" effector and immunoregulatory cells: recent advances. Annu Rev Immunol. 2005a;23:749-786.
Galli SJ, Nakae S, Tsai M: Mast cells in the development of adaptive immune responses. Nat Immunol. 2005b;6:135-142.
Hu S, Du MH, Luo HM, Wang H, Lv Y, Ma L, Lin ZL, Shi X, Gaischek I, Wang L, Litscher G. Electroacupuncture at Zusanli (ST36) Prevents Intestinal Barrier and Remote Organ Dysfunction following Gut Ischemia through Activating the Cholinergic Anti-Inflammatory-Dependent Mechanism. Evid Based Complement Alternat Med. 2013;2013:592127.
Katayama S, Shionoya H, Ohtake S. A new method for extraction of extravasated dye in the skin and the influence of fasting stress on passive cutaneous allergy in guinea pigs and rats. Microbiol Immunol. 1978;22:89-101.
Kim J, Kang DI. A descriptive statistical approach to the Korean pharmacopuncture therapy. J Acupunct Meridian Stud. 2010;3:141-149.
Miescher SM, Vogel M. Molecular aspects of allergy. Mol Aspects Med. 2002;23:413-462.
Moon PD, Choi IY, Na HJ, Jeong HJ, Kim CH, Kim HR, Kim YK, Park SK, Hong SH, Kim HM. Rubus croceacanthus Leveille inhibits mast cell-mediated anaphylactic-like reaction and tumor necrosis factor-a secretion. Biol Pharm Bull. 2004;27:1359-1363.
Moon PD, Na HJ, Jeong HJ, Hong SH, Kim SJ, Chae HJ, Kim HR, Choi JO, Lee SH, Shin JY, Kim HM. Inhibitory effect of Gamibojungikgitang extract on mast cell-mediated allergic reaction in murine model. J Pharm Pharm Sci. 2005;8:94-101.
Mousli MC, Bronner C, Bockaert J, Rouot B, Landry Y. Interaction of substance P, compound 48/80 and mastoparan with a-subunit C-terminal of G protein. Immunol Lett. 1990a;25:355-358.
Mousli MC, Bronner C, Landry Y, Bockaert J, Rouot B. Direct activation of GTP-binding regulatory proteins (G proteins) by substance P and compound 48/80. FEBS Lett. 1990b;25:260-262.
Petersen LJ, Mosbech H, Skov PS. Allergen-induced histamine release in intact human skin in vivo assessed by skin microdialysis technique: characterization of factors influencing histamine releasability. J Allergy Clin Immunol. 1996;97:672-679.
Puignero V, Salgado J, Queralt J. Effects of cyclosporine and dexamethasone on IgE antibody response in mice, and on passive cutaneous anaphylaxis in the rat. Int Arch Allergy Immunol. 1995;108:142-147.
Royer B, Varadaradjalou S, Saas P, Gabiot AC, Kantelip B, Feger F, Guillosson JJ, Kantelip JP, Arock M. Autocrine regulation of cord blood-derived human mast cell activation by IL-10. J Allergy Clin Immunol. 2001;108:80-86.
Shin HY, Na HJ, Moon PD, Shin T, Shin TY, Kim SH, Hong SH, Kim HM. Inhibition of mast cell-dependent immediate-type hypersensitivity reactions by purple bamboo salt. J Ethnopharmacol. 2004;91:153-157.
Stassen M, Muller C, Arnold M, Hultner L, Klein-Hessling S, Neudorfl C, Reineke T, Serfling E, Schmitt E. IL-9 and IL-13 production by activated mast cells is strongly enhanced in the presence of lipopolysaccharide: NF-kappa B is decisively involved in the expression of IL-9. J Immunol. 2001;166:4391-4398.
Tasaka K, Mio M, Okamoto M. Intracellular calcium release induced by histamine releasers and its inhibition by some antiallergic drugs. Ann Allergy Asthma Immunol. 1986;56:464-469.
Thompson BT. Glucocorticoids and acute lung injury. Crit Care Med. 2003;31:S253-S257.
Verdier F, Chazal I, Descotes J. Anaphylaxis models in the guinea-pig. Toxicology. 1994;93:55-61.
Wershil BK, Furuta GT, Lavigne JA, Choudhury AR, Wang ZS, Galli SJ. Dexamethasone or cyclosporin A suppress mast cell-leukocyte cytokine cascades. Multiple mechanisms of inhibition of IgE- and mast cell-dependent cutaneous inflammation in the mouse. J Immunol. 1995;154:1391-1398.
Wershil BK, Mekori YA, Murakami T, Galli SJ. 125I-fibrin deposition in IgE-dependent immediate hypersensitivity reactions in mouse skin. Demonstration of the role of mast cells using genetically mast cell-deficient mice locally reconstituted with cultured mast cells. J Immunol. 1987;139:2605-2614.